These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 26909157)
1. Emerging non-PCV13 serotypes of noninvasive Streptococcus pneumoniae with macrolide resistance genes in northern Japan. Kawaguchiya M; Urushibara N; Aung MS; Morimoto S; Ito M; Kudo K; Sumi A; Kobayashi N New Microbes New Infect; 2016 Jan; 9():66-72. PubMed ID: 26909157 [TBL] [Abstract][Full Text] [Related]
2. Serotype distribution and susceptibility to penicillin and erythromycin among noninvasive or colonization isolates of Streptococcus pneumoniae in northern Japan: a cross-sectional study in the pre-PCV7 routine immunization period. Kawaguchiya M; Urushibara N; Ghosh S; Kuwahara O; Morimoto S; Ito M; Kudo K; Kobayashi N Microb Drug Resist; 2014 Oct; 20(5):456-65. PubMed ID: 24766085 [TBL] [Abstract][Full Text] [Related]
3. High prevalence of antimicrobial resistance in non-vaccine serotypes of non-invasive/colonization isolates of Streptococcus pneumoniae: A cross-sectional study eight years after the licensure of conjugate vaccine in Japan. Kawaguchiya M; Urushibara N; Aung MS; Ito M; Takahashi A; Habadera S; Kobayashi N J Infect Public Health; 2020 Aug; 13(8):1094-1100. PubMed ID: 32446777 [TBL] [Abstract][Full Text] [Related]
4. Serotype distribution, antimicrobial resistance and prevalence of pilus islets in pneumococci following the use of conjugate vaccines. Kawaguchiya M; Urushibara N; Aung MS; Shinagawa M; Takahashi S; Kobayashi N J Med Microbiol; 2017 May; 66(5):643-650. PubMed ID: 28516842 [TBL] [Abstract][Full Text] [Related]
5. Emerging Streptococcus pneumoniae Strains Colonizing the Nasopharynx in Children After 13-valent Pneumococcal Conjugate Vaccination in Comparison to the 7-valent Era, 2006-2015. Kaur R; Casey JR; Pichichero ME Pediatr Infect Dis J; 2016 Aug; 35(8):901-6. PubMed ID: 27420806 [TBL] [Abstract][Full Text] [Related]
6. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014. Nakano S; Fujisawa T; Ito Y; Chang B; Suga S; Noguchi T; Yamamoto M; Matsumura Y; Nagao M; Takakura S; Ohnishi M; Ihara T; Ichiyama S Vaccine; 2016 Jan; 34(1):67-76. PubMed ID: 26602268 [TBL] [Abstract][Full Text] [Related]
7. Dynamics of pneumococcal carriage among day-care center attendees during the transition from the 7-valent to the higher-valent pneumococcal conjugate vaccines in Greece. Grivea IN; Priftis KN; Giotas A; Kotzia D; Tsantouli AG; Douros K; Michoula AN; Syrogiannopoulos GA Vaccine; 2014 Nov; 32(48):6513-20. PubMed ID: 25252194 [TBL] [Abstract][Full Text] [Related]
8. Decline in Pneumococcal Nasopharyngeal Carriage of Vaccine Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Children in Atlanta, Georgia. Desai AP; Sharma D; Crispell EK; Baughman W; Thomas S; Tunali A; Sherwood L; Zmitrovich A; Jerris R; Satola SW; Beall B; Moore MR; Jain S; Farley MM Pediatr Infect Dis J; 2015 Nov; 34(11):1168-74. PubMed ID: 26226445 [TBL] [Abstract][Full Text] [Related]
9. Serotype Distribution and Antimicrobial Susceptibility of Wu CJ; Lai JF; Huang IW; Shiau YR; Wang HY; Lauderdale TL Front Microbiol; 2020; 11():557404. PubMed ID: 33193140 [TBL] [Abstract][Full Text] [Related]
10. Impact of the pneumococcal conjugate vaccine on serotype distribution of adult non-invasive Streptococcus pneumoniae isolates in Tokai region, Japan, 2008-2016. Furuya Y; Yamagishi Y; Okade H; Kadota T; Funatsu T; Eto M; Nomura N; Mitsuyama J; Mikamo H J Infect Chemother; 2017 Jun; 23(6):394-399. PubMed ID: 28427991 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of the seven-valent and thirteen-valent pneumococcal conjugate vaccines in England: The indirect cohort design, 2006-2018. Andrews N; Kent A; Amin-Chowdhury Z; Sheppard C; Fry N; Ramsay M; Ladhani SN Vaccine; 2019 Jul; 37(32):4491-4498. PubMed ID: 31272872 [TBL] [Abstract][Full Text] [Related]
12. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway. Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490 [TBL] [Abstract][Full Text] [Related]
13. Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era. Zuccotti G; Mameli C; Daprai L; Garlaschi ML; Dilillo D; Bedogni G; Faccini M; Gramegna M; Torresani E; ; Ballerini E; Benincaso A; Bonvissuto M; Bricalli D; Brioschi M; Calloni CS; Camiletti MI; Colella G; De Angelis L; Decarlis S; Di Nello F; Dozzi M; Galli E; Gandini V; Giuliani MG; Laviola F; Loda B; Macedoni M; Mazzucchi E; Metta MG; Moscatiello A; Nannini P; Petruzzi M; Picicco D; Picciotti M; Pisanelli S; Porta N; Ramponi G; Redaelli F; Rubini R; Sala N; Saitta V; Scelza G; Tiso RM; Tomasetto M; Torcoletti M; Travaini M; Valentini M; Vessia C Vaccine; 2014 Jan; 32(5):527-34. PubMed ID: 24342249 [TBL] [Abstract][Full Text] [Related]
14. Nationwide population-based surveillance of invasive pneumococcal disease in Japanese children: Effects of the seven-valent pneumococcal conjugate vaccine. Suga S; Chang B; Asada K; Akeda H; Nishi J; Okada K; Wakiguchi H; Maeda A; Oda M; Ishiwada N; Saitoh A; Oishi T; Hosoya M; Togashi T; Oishi K; Ihara T Vaccine; 2015 Nov; 33(45):6054-60. PubMed ID: 26235372 [TBL] [Abstract][Full Text] [Related]
15. Multidrug Resistance in Non-PCV13 Serotypes of Streptococcus pneumoniae in Northern Japan, 2014. Kawaguchiya M; Urushibara N; Kobayashi N Microb Drug Resist; 2017 Mar; 23(2):206-214. PubMed ID: 27257915 [TBL] [Abstract][Full Text] [Related]
16. Pneumococcal serotype evolution in Western Europe. Tin Tin Htar M; Christopoulou D; Schmitt HJ BMC Infect Dis; 2015 Oct; 15():419. PubMed ID: 26468008 [TBL] [Abstract][Full Text] [Related]
17. Near-elimination of otitis media caused by 13-valent pneumococcal conjugate vaccine (PCV) serotypes in southern Israel shortly after sequential introduction of 7-valent/13-valent PCV. Ben-Shimol S; Givon-Lavi N; Leibovitz E; Raiz S; Greenberg D; Dagan R Clin Infect Dis; 2014 Dec; 59(12):1724-32. PubMed ID: 25159581 [TBL] [Abstract][Full Text] [Related]
18. Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine. Sharma D; Baughman W; Holst A; Thomas S; Jackson D; da Gloria Carvalho M; Beall B; Satola S; Jerris R; Jain S; Farley MM; Nuorti JP Pediatr Infect Dis J; 2013 Feb; 32(2):e45-53. PubMed ID: 23080290 [TBL] [Abstract][Full Text] [Related]
19. Conjugate vaccine serotypes persist as major causes of non-invasive pneumococcal pneumonia in Portugal despite declines in serotypes 3 and 19A (2012-2015). Horácio AN; Silva-Costa C; Lopes E; Ramirez M; Melo-Cristino J; PLoS One; 2018; 13(11):e0206912. PubMed ID: 30388168 [TBL] [Abstract][Full Text] [Related]
20. A Population-Based Descriptive Atlas of Invasive Pneumococcal Strains Recovered Within the U.S. During 2015-2016. Beall B; Chochua S; Gertz RE; Li Y; Li Z; McGee L; Metcalf BJ; Ricaldi J; Tran T; Walker H; Pilishvili T Front Microbiol; 2018; 9():2670. PubMed ID: 30524382 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]